GAA
GILD icon

Green Alpha Advisors’s Gilead Sciences GILD Stock Holding History

Green Alpha Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24,522
Closed -$1.52M – 146
2022
Q2 		$1.52M Buy
+24,522
New +$1.52M 0.35% 61
2021
Q2 		– Sell
-4,338
Closed -$280K – 133
2021
Q1 		$280K Sell
4,338
-2,186
-34% -$141K 0.28% 100
2020
Q4 		$380K Buy
+6,524
New +$394K 0.46% 78

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Green Alpha Advisors's GILD Position: Q3 2022 in Review

Green Alpha Advisors sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 24,522 shares — an estimated $1.52M sold.

Green Alpha Advisors first reported a position in GILD in Q4 2020 and held it in 3 quarters. The position peaked at $1.52M in Q2 2022. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • Green Alpha Advisors reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
  • Green Alpha Advisors sold 24,522 Gilead Sciences shares in Q3 2022, an estimated $1.52M.
  • Green Alpha Advisors first reported a position in Gilead Sciences in Q4 2020 and held it in 3 quarters.
  • Green Alpha Advisors's Gilead Sciences position peaked at $1.52M in Q2 2022.
  • 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Green Alpha Advisors's 13F filing for Q3 2022, filed 14 Oct 2022.